BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 30979857)

  • 1. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA
    de Bruijn MAAM; van Sonderen A; van Coevorden-Hameete MH; Bastiaansen AEM; Schreurs MWJ; Rouhl RPW; van Donselaar CA; Majoie MHJM; Neuteboom RF; Sillevis Smitt PAE; Thijs RD; Titulaer MJ
    Neurology; 2019 May; 92(19):e2185-e2196. PubMed ID: 30979857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
    Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA
    Rada A; Hagemann A; Aaberg Poulsen C; Baumgartner T; Berki T; Blaabjerg M; Brenner J; Britton JW; Christiana A; Ciano-Petersen NL; Crijnen Y; Elišák M; Farina A; Friedman AR; Hayden Z; Hébert J; Holtkamp M; Hong Z; Honnorat J; Ilyas-Feldmann M; Irani SR; Kovac S; Marusic P; Muñiz-Castrillo S; Ramanathan S; Smith KM; Steriade C; Strippel C; Surges R; Titulaer MJ; Uy CE; de Vries JM; Bien CG; Specht U
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200225. PubMed ID: 38838283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
    Zhang W; Wang X; Shao N; Ma R; Meng H
    Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Symptomatic Seizures and Risk of Seizure Recurrence in Patients with Anti-NMDAR, Anti-LGI1, and Anti-GABA
    Cui D; Feng J; Yang M; Dong Y; Lian Y
    Neurol Sci; 2024 Apr; 45(4):1609-1617. PubMed ID: 37940748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
    Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
    J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
    Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
    Front Neurol; 2020; 11():280. PubMed ID: 32431657
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update.
    Liu X; Guo K; Lin J; Gong X; Li A; Zhou D; Hong Z
    Epilepsia; 2022 Jul; 63(7):1812-1821. PubMed ID: 35357695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1.
    Feyissa AM; Lamb C; Pittock SJ; Gadoth A; McKeon A; Klein CJ; Britton JW
    Epilepsia Open; 2018 Sep; 3(3):348-356. PubMed ID: 30187005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study.
    Liu X; Yan B; Wang R; Li C; Chen C; Zhou D; Hong Z
    Epilepsia; 2017 Dec; 58(12):2104-2111. PubMed ID: 29098690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Seizure and Antiepileptic Drug Utilization in Outpatients With Autoimmune Encephalitis.
    Huang Q; Ma M; Wei X; Liao Y; Qi H; Wu Y; Wu Y
    Front Neurol; 2018; 9():1136. PubMed ID: 30671012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcome-related factors of seizure at the first onset of autoimmune encephalitis: A retrospective study.
    Wang Y; Li X; He P; Yin J; Dong R; Fu Y; Zhang H
    CNS Neurosci Ther; 2021 Jun; 27(6):694-701. PubMed ID: 33683811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis.
    Zhong R; Chen Q; Zhang X; Zhang H; Lin W
    Front Immunol; 2022; 13():845365. PubMed ID: 35320933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between seizures and MRI in patients with anti-NMDAR encephalitis.
    Ni G; Lin W; Cai X; Qin J; Feng L; Zhu S; Zhou L; Chen Z
    Acta Neurol Scand; 2020 Nov; 142(5):460-465. PubMed ID: 32533702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
    Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased adverse events associated with antiepileptic drugs in anti-leucine-rich glioma-inactivated protein 1 encephalitis.
    Shin YW; Ahn SJ; Moon J; Kim TJ; Jun JS; Byun JI; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee SK; Chu K
    Epilepsia; 2018 Oct; 59 Suppl 2():108-112. PubMed ID: 30159879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure Semiology in Antibody-Associated Autoimmune Encephalitis.
    Kaaden T; Madlener M; Angstwurm K; Bien CG; Bogarin Y; Doppler K; Finke A; Gerner ST; Reimann G; Häusler M; Handreka R; Hellwig K; Kaufmann M; Kellinghaus C; Koertvelyessy P; Kraft A; Lewerenz J; Menge T; Paliantonis A; von Podewils F; Prüss H; Rauer S; Ringelstein M; Rostásy K; Schirotzek I; Schwabe J; Sokolowski P; Suesse M; Sühs KW; Surges R; Tauber SC; Thaler F; Bergh FT; Urbanek C; Wandinger KP; Wildemann B; Mues S; Zettl U; Leypoldt F; Melzer N; Geis C; Malter M; Kunze A;
    Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis.
    Pişkin ŞA; Korkmaz HY; Ulusoy CA; Şanlı E; Küçükali CI; Onat F; Tüzün E; Çarçak N
    Front Immunol; 2023; 14():1268986. PubMed ID: 38035091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants for Control of Status Epilepticus in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Yen HK; Tang SC; Tsai LK; Fan SP; Yeh SJ; Jeng JS
    Acta Neurol Taiwan; 2021 Mar; 30(1)():1-10. PubMed ID: 34549395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune Encephalitis Resembling Dementia Syndromes.
    Bastiaansen AEM; van Steenhoven RW; de Bruijn MAAM; Crijnen YS; van Sonderen A; van Coevorden-Hameete MH; Nühn MM; Verbeek MM; Schreurs MWJ; Sillevis Smitt PAE; de Vries JM; Jan de Jong F; Titulaer MJ
    Neurol Neuroimmunol Neuroinflamm; 2021 Sep; 8(5):. PubMed ID: 34341093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.